Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation
Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation. // Clinical Immunology. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626000938?dgcid=rss_sd_all
Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation. Clinical Immunology. https://www.sciencedirect.com/science/article/pii/S1521661626000938?dgcid=rss_sd_all
“Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation.” Clinical Immunology.
@article{article339,
title = {Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation},
journal = {Clinical Immunology},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626000938?dgcid=rss_sd_all}
}